Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

NCT07530588 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-04-15

No results posted yet for this study

Summary

The DIRECT-CT trial is designed to test the hypothesis that remote controlled CT scanning combined with real time audio-and video conference (AVC) guided assessment from an experienced hospital stroke team (tele-stroke) at decentralized medical centers (DMC) reduces time to intravenous thrombolytic treatment compared to the standard pathway.

Conditions

Interventions

OTHER

Decentralized diagnostics and treatment

The intervention includes admittance to the DMC for initial diagnostic work up and acute treatment (if indicated). Paramedics examine the patient and assess stroke severity by NIHSS and G-FAST scoring overseen by a stroke physician at the local hospital through real time video conference. A remote controlled CT scan of the head is conducted, and the stroke team at the local hospital evaluates results and makes a treatment decision in real-time AVC. If treatment is indicated, this is administered by local personnel at the DMC before initiating transport to the local hospital or the comprehensive stroke center in case of LVO. Patients who are unable to reach the DMC prior to estimated admission time at their local hospital, will be treated at their local hospital as per standard pathway.

Sponsors & Collaborators

  • Helgelandssykehuset Hospital Trust

    collaborator UNKNOWN
  • Nordlandssykehuset Hospital Trust

    collaborator UNKNOWN
  • Finnmarkssykehuset HF

    collaborator UNKNOWN
  • UiT The Arctic University of Norway

    collaborator OTHER
  • Innlandet Central Hospital HF, Lillehammer

    collaborator UNKNOWN
  • Oslo University Hospital

    collaborator OTHER
  • Ringerike hospital HF, Hønefoss Norway

    collaborator UNKNOWN
  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Tor Ingebrigtsen, MD, PhD · University Hospital of North Norway

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-17
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07530588 on ClinicalTrials.gov